What's Happening?
A recent study conducted by University College London, with support from the University of Exeter, has found no evidence that hormone replacement therapy (HRT) affects the risk of dementia. The research reviewed data from over one million women and concluded
that HRT does not significantly alter the risk of mild cognitive impairment (MCI), a precursor to dementia. This study was part of a larger review commissioned by the World Health Organization. The findings suggest that decisions regarding HRT should not be influenced by concerns about dementia risk.
Why It's Important?
The study provides clarity for millions of women considering HRT for menopausal symptoms, alleviating concerns about potential cognitive risks. This could influence healthcare guidelines and patient decisions, ensuring that HRT is prescribed based on its benefits for menopausal symptoms rather than unfounded fears of dementia. The research reinforces current clinical guidance and highlights the need for further studies to explore the relationship between menopause treatments and cognitive health.
